Management of stage III primary breast c
โ
Gabriel N. Hortobagyi; F. C. Ames; A. U. Buzdar; S. W. Kau; M. D. McNeese; D. Pa
๐
Article
๐
1988
๐
John Wiley and Sons
๐
English
โ 970 KB
One hundred seventy-four evaluable patients with noninflammatory Stage III (both operable and inoperable) breast cancer were treated with a combined modality strategy between 1974 and 1985. All patients received combination chemotherapy with 5-fluorouracil, Adriamycin (doxorubicin), and cyclophospha